Quantcast
Tag archive for ‘fungal drug’
By Robert Herriman On Sunday, March 16th, 2014
0 Comments

Noxafil antifungal agent for invasive Aspergillus and Candida prophylaxis gets FDA approval

PRESS RELEASE The U.S. Food and Drug Administration has approved NOXAFIL® (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use. Merck’s antifungal agent is also marketed More...

By Robert Herriman On Friday, February 28th, 2014
0 Comments

Swiss pharma company, Basilea, receives FDA Qualified Infectious Disease Product designation for fungal drug, isavuconazole

PRESS RELEASE Basilea Pharmaceutica Ltd. announced Thursday that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive More...


Recent Posts

December 6, 2019, Comments Off on

December 6, 2019, Comments Off on

December 4, 2019, Comments Off on

December 4, 2019, Comments Off on

DISPATCH BLOGS

Splash Page logo 300x146 Today in History